Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Operating expenses:
Research and development	$ 6,218	$ 3,466	$ 18,608	$ 11,819
General and administrative	4,482	4,508	13,964	15,734
Total operating expenses	10,700	7,974	32,572	27,553
Loss from operations	(10,700)	(7,974)	(32,572)	(27,553)
Other income (expense), net:
Interest and investment income	840	283	2,373	568
Other income (expense), net	840	283	2,373	568
Net loss	$ (9,860)	$ (7,691)	$ (30,199)	$ (26,985)
Net loss per share attributable to common stockholders, basic and diluted (in Dollars per share)	$ (0.87)	$ (0.68)	$ (2.67)	$ (2.4)
Weighted-average shares outstanding, basic and diluted (in Shares)	11,347,887	11,265,475	11,320,027	11,256,995
Other comprehensive income (loss):
Net unrealized gain (loss) on marketable debt securities	$ 171	$ (8)	$ 523	$ (919)
Other comprehensive income (loss)	171	(8)	523	(919)
Comprehensive Loss	$ (9,689)	$ (7,699)	$ (29,676)	$ (27,904)